Mersana Therapeutics, Inc. Quarterly Other Assets, Noncurrent in USD from Q4 2016 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Mersana Therapeutics, Inc. quarterly Other Assets, Noncurrent history and growth rate from Q4 2016 to Q2 2024.
  • Mersana Therapeutics, Inc. Other Assets, Noncurrent for the quarter ending June 30, 2024 was $978K, a 89.2% increase year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $978K +$461K +89.2% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $478K -$110K -18.7% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $478K -$183K -27.7% Dec 31, 2023 10-Q 2024-08-13
Q3 2023 $478K -$138K -22.4% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $517K -$207K -28.6% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $588K -$1.66M -73.8% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $661K -$1.7M -71.9% Dec 31, 2022 10-K 2024-02-28
Q3 2022 $616K -$2.31M -79% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 $724K -$3.88M -84.3% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $2.25M -$1.27M -36.2% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $2.36M +$203K +9.43% Dec 31, 2021 10-K 2023-02-28
Q3 2021 $2.93M +$775K +36% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $4.61M +$2.5M +119% Jun 30, 2021 10-Q 2021-08-06
Q1 2021 $3.52M +$2.07M +142% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $2.15M +$700K +48.2% Dec 31, 2020 10-K 2022-02-28
Q3 2020 $2.15M +$700K +48.2% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $2.1M +$600K +39.9% Jun 30, 2020 10-Q 2020-08-07
Q1 2020 $1.45M -$50K -3.33% Mar 31, 2020 10-Q 2020-05-08
Q4 2019 $1.45M -$50K -3.33% Dec 31, 2019 10-K 2021-02-26
Q3 2019 $1.45M -$351K -19.5% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 $1.5M -$467K -23.7% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $1.5M -$301K -16.7% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 $1.5M +$1.13M +305% Dec 31, 2018 10-K 2020-02-28
Q3 2018 $1.8M +$1.42M +370% Sep 30, 2018 10-Q 2018-11-13
Q2 2018 $1.97M -$1.31M -40% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 $1.8M Mar 31, 2018 10-Q 2018-05-15
Q4 2017 $371K -$60K -13.9% Dec 31, 2017 10-K 2019-03-08
Q3 2017 $384K Sep 30, 2017 10-Q 2017-11-13
Q2 2017 $3.28M Jun 30, 2017 10-Q 2017-08-11
Q4 2016 $431K Dec 31, 2016 10-K 2018-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.